Resident cells of the myocardium:more than spectators in cardiac injury, repair and regeneration by Gray, G A et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Resident cells of the myocardium:more than spectators in
cardiac injury, repair and regeneration
Citation for published version:
Gray, GA, Toor, IS, Castellan, R, Crisan, M & Meloni, M 2018, 'Resident cells of the myocardium:more than
spectators in cardiac injury, repair and regeneration' Current opinion in physiology, vol. 1, pp. 46-51. DOI:
10.1016/j.cophys.2017.08.001
Digital Object Identifier (DOI):
10.1016/j.cophys.2017.08.001
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Current opinion in physiology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 09. May. 2019
Resident cells of the myocardium: more than spectators in
cardiac injury, repair and regeneration
GA Gray1, IS Toor1, RFP Castellan1, M Crisan1,2 and M Meloni1
Available online at www.sciencedirect.com
ScienceDirectMultiple resident cell types contribute to maintaining the
structure and physiological function of the heart over the life
course. Cardiomyocyte proliferation supports scar free
regeneration in the neonatal heart following injury, but a lower
rate of proliferation in the adult necessitates replacement by a
collagen scar to maintain ventricular integrity. In this short
review we discuss recent studies that have identified novel
roles for non-myocyte resident cells and the extracellular matrix
in supporting repair, as well as cardiomyocyte and vascular
regeneration, following myocardial infarction.
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Given the role of the heart as a muscular pump, cardiac
muscle cells, or cardiomyocytes, are clearly key among
resident cells. However, the majority of myocardial cells
are non-myocytes, including endothelial cells in the cor-
onary vasculature, lymphatics and endocardium, fibro-
blasts, pericytes, neurons, stem cells and immune cells
[1], that each have homeostatic functions to maintain the
structure and function of the heart. Cardiac injury follow-
ing myocardial infarction (MI), is accompanied by necro-
sis, as well as programmed cell death by apoptosis and
necroptosis [2], that reduces cardiac contractile capacity.
Adult cardiomyocytes have very limited potential for
proliferation, and while this can increase to some extent
following injury, the rate is too slow (approx. 0.5–2% per
year) to replace the large number of cardiomyocytes lost
after MI [3]. Therefore, following cardiomyocyte loss
the remaining tissue resident cells variably proliferate,
alter their phenotype, transdifferentiate, secrete enzymes,
chemical mediators and other intracellular material, forCurrent Opinion in Physiology 2018, 1:46–51 example exosomes [4], to reorganize the matrix and recruit
cells necessary for repair. This ensures the formation of
collagen scar to maintain the integrity of the heart and its
pump function. In this short review we shall focus on
recent discoveries with regard to cardiac resident cells,
their actions and interactions following injury.
Cardiomyocytes
Cardiomyocytes account for 20–35% of cells in mouse [5]
and human hearts [6], and despite rapid intervention to
restore blood supply following MI, significant numbers
are lost due to ischemia and to reperfusion injury. Far
from being an innocuous event, cardiomyocyte death
itself provides the first stimulus for repair by releasing
damage associated molecular patterns (DAMPS, or alar-
mins). These signals activate pattern recognition recep-
tors on neighboring cells, including fibroblasts [6,7], to
initiate recruitment of inflammatory cells. The engulf-
ment of apoptotic cardiomyocytes by macrophages, dur-
ing efferocytosis [8], and also by resident fibroblast
derived myofibroblasts [9], additionally regulates infarct
repair by enhancing acquisition of a phenotype that
promotes inflammation of resolution.
Various progenitor cell populations can be identified in the
heart, although they are relatively rare, and the extent to
which they contribute to new cardiomyocyte generation
seems to be low [3]. Although still an area of some
controversy, the current consensus is that any limited
generation of new cardiomyocytes that does occur is pre-
dominantly by cell cycle re-entry of existing adult cardi-
omyocytes [3,10]. The challenge is now to understand
why the proliferation rate in the adult fails to achieve that
which supports full regeneration of the neonatal heart
following MI. Interestingly, the extracellular matrix is
emerging as an endogenous regulator of cardiac regenera-
tion. In a recent study Basset et al. [11] provided evidence
for promotion of cardiomyocyte proliferation by extracel-
lular matrix derived agrin, through Yap and ERK mediated
signaling, enabling cardiac regeneration in neonatal mice
following MI. One of the potential roadblocks to cardiac
regeneration is the relatively high pressure within the adult
mammalian heart [10]. In this regard it is intriguing that
mechanical unloading in humans, following implantation
of a left-ventricular assist device, resulted in enhancement
of cardiomyocyte proliferation [12]. It is feasible to specu-
late that the associated changes in mechanical strain might
link extracellular matrix signaling to this outcome. Hypoxia
also enhances adult cardiomyocyte proliferation, through
alteration of redox signaling and mitochondrial mass, andwww.sciencedirect.com
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exposure to hypoxic environment, resulting in improved
outcomes post-MI [13].
Endothelial cells
Endothelial cells (ECs) make up the largest proportion
(60%) of non-myocytes in the adult heart, at least in the
mouse [1]. They have a number of essential roles in heart
development, in vascular homeostasis, in promoting car-
diomyocyte organization and survival, as well as in heal-
ing and regeneration post-ischemic injury. Following MI,
neovascularization increases the density of peri-infarct
vessels thus enhancing perfusion and limiting further loss
of cardiomyocytes around the infarct zone. Genetic-line-
age tracing has revealed that angiogenesis post-MI occurs
preferentially from pre-existing adult ECs, rather than
through transdifferentiation from other cell lineages [14].
These new data also suggest that recruited bone marrow
derived endothelial progenitor cells might be less impor-
tant for post-MI angiogenesis than previously proposed.
Effective neovascularization following MI requires mat-
uration of nascent vessels through acquisition of a mural
coat. Chen et al. have now shown that endocardial ECs
undergo endothelial to mesenchymal transition (EndMT)
to give rise to PDGFRb+ mural cells (pericytes and vas-
cular smooth muscle cells) during embryonic development
[15]. As developmental programmes are frequently re-
initiated during remodeling in response to MI or pressure
overload, it will be of interest in future to investigate
whether neovascularization invokes this pathway, to com-
plement recruitment of resident pericytes during vessel
maturation [16]. Investigation of mechanisms for endoge-
nous promotion of angiogenesis continues to identify new
pathways that might be exploited to therapeutically
enhance angiogenesis in the post-MI setting by acting
directly on ECs, for example, CXCR7 [17], micro RNAs
[18] and long noncoding RNAs [19], or indirectly via
actions in other resident cells, for example, locally regen-
erated glucocorticoids [20]. The endothelium of lymphatic
vessels serves as a barrier to control fluid balance and
immune cell trafficking in maintenance of tissue homeo-
stasis. Lymphangiogenesis, the formation of new lym-
phatic vessels from pre-existing vessels, is also increased
post-MI [21]. While in other settings this can have detri-
mental effects, enhancement in the heart following admin-
istration of vascular endothelial growth factor (VEGF)-C
was reported to improve structural and functional remo-
deling post-MI [21]. Promotion of lymphatic vessel matu-
ration by apelin may offer further benefit [22].
Vascular ECs are also a key site for regulation of inflamma-
tory cell recruitment following MI. Senescent ECs have
impaired capacity for inflammatory regulation [23], and this
may contribute to altered responses to myocardial injury in
aging. In addition to generation of mural cells, EndMT,
under the influence of TGFb and loss of signals maintaining
the EC phenotype, allows EC to contribute to the fibroblastwww.sciencedirect.com population in the heart [24]. However, the importance of
these cells, relative to resident fibroblasts, in contributing
to scar formation remains the subject of debate [25].
Fibroblasts
Resident fibroblasts are among the most represented cell
populations of the heart, although a recent elegant study
has shown that the proportion may be <20% in the mouse
heart, significantly less than previously suggested [1].
Nevertheless they have a key homeostatic role in synthesis
of the cardiac extracellular matrix, and undergo phenotype
conversion to proliferative myofibroblasts following MI to
augment matrix production, ensuring scar formation [7].
The recent availability of new mouse strains that allow
tracking of fibroblast and myofibroblast behavior following
myocardial injury has helped to reveal a surprising diversity
in their roles [26]. This includes the novel observation that
myofibroblasts phagocytose apoptotic cells in the heart
following MI [9]. Knockout of the milk fat globule-
epidermal growth factor 8, that is secreted by myofibro-
blasts to enable phagocytosis, resulted in impaired clear-
ance of apoptotic cells, and increased mortality [9]. (Myo)
fibroblasts are an important source of inflammatory med-
iators in the heart, including those responsible for neutro-
phil recruitment [7,27]. The fibroblast phenotype is deter-
mined by inputs from other cells in the microenvironment
within the heart, for example DAMPS, and interleukin
(IL)-1 that promote inflammation, and apoptotic cells that
are anti-inflammatory. Crosstalk with ECs and with macro-
phages ensures promotion of angiogenesis and matrix
synthesis. There is much still to learn about cardiac
(myo) fibroblasts [28], and the ability to target genetic
modification to fibroblasts or specifically to myofibroblasts
[29], will undoubtedly lead to greater understanding of
their roles and interactions during wound repair. Trans-
differentation of fibroblasts to ECs can occur during mes-
enchymal to EC transition (MEndT) in vitro, but whether
this contribute significantly to EC generation in vivo is less
clear [14]. In situ reprogramming of cardiac fibroblasts to
cardiomyocytes by administration of transcription factors
or microRNAs has generated excitement in the regenera-
tive medicine field, and the search for small molecule
alternatives to allow pharmacological intervention holds
much promise for translation of this approach [30].
Pericytes
Pericytes are smooth muscle like cells of mesenchymal
origin that surround capillary ECs of the heart, and also have
multipotent progenitor potential [31]. Cell–cell contact
between pericytes and EC maintains them in a quiescent
state, and initiation of angiogenesis requires the detach-
ment of pericytes to enable EC migration (Figure 1). Vice
versa, pericyte recruitment stabilizes and matures nascent
vessels. In a new study, Teichert et al. [16] have revealed an
essential role for angiopoietin/Tie 2 signaling in regulating
these interactions via the Tie 2 receptor expressed on
pericytes, in addition to ECs. In other tissues, pericytesCurrent Opinion in Physiology 2018, 1:46–51
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New blood vessel formation and maturation requires communication between endothelial cells (ECs) and pericytes (PCs) through paracrine
factors. (a) A quiescent capillary: cell–cell contact between ECs (in white) and PCs (in yellow) maintains capillaries in a quiescent state, in part
through the actions of pericyte derived angiopoetin 1 (Ang 1) on EC Tie 2 receptors. (b) Cardiac injury (MI) triggers neovascularisation (from pre-
existing adult ECs — in pink) and ECs release Ang 2 that prevents access of Ang 1 to EC Tie 2 receptors and allows EC sprouting and pericyte
detachment. Sprouting ECs also release MMPs that promote pericyte detachment and EC migration. (c) PDGFB is released by ECs during the
elongation process. Pericytes expressing the PDGFRb are recruited to stabilize and mature the new vessels (d). Maturation is also promoted by
the binding of Ang 1 to pericyte Tie 2 receptors.are important regulators of immune cell recruitment
[32,33,34,35], and they are also likely to have this role
in the heart following MI. Pericytes are progenitors of
multiple cell types in vitro, and when administered to
the mouse heart in vivo following MI can contribute to
development of new cardiomyocytes, albeit in limited
manner [31]. Pericytes can also assume a collagen synthe-
sizing phenotype and contribute to tissue fibrosis [36]. The
extent to which pericytes behave as mesenchymal cells in
vivo is the subject of some controversy [37], and further
lineage tracking studies are required to investigate the roles
of these cells during repair and regeneration in the heart.
Immune cells
Immune cells, including monocytes and neutrophils, are
rapidly recruited in large numbers to the heart following
injury [38], but there is also a significant resident repre-
sentation before injury, including macrophages and small
populations of B and T cells, in the mouse heart [1].
Mast cells, long established as resident cardiac immune
cells, function as key effectors of the innate immune
response and their strategic perivascular location allows
preformed stores of inflammatory mediators to be released
into the blood when they rapidly degranulate following MI
[38]. Recent studies have shown that mast cell derivedCurrent Opinion in Physiology 2018, 1:46–51 renin activates the local renin-angiotensin system [39], and
mast cell derived chymase can degrade insulin-like growth
factor-1 [40], increasing ischemic cardiac injury and detri-
mental remodeling following MI.
Although a resident macrophage population (Figure 2)
has only relatively recently been described in the heart
[41,42], it is the subject of intense current scrutiny with
regard to roles in physiology and pathophysiology [43].
Originating from the fetal yolk sac and liver, with an
increasing contribution from bone marrow derived cells in
the adult [44] (Figure 1), the resident cardiac macrophage
population is relatively sparse in healthy hearts, and
phagocytically active, consistent with a janitorial homeo-
static role [42,45]. Identification of increased macrophage
density in the atrio-ventricular conducting system has
recently led to discovery of an unexpected role in facili-
tation of electrical conduction in the heart [46]. Follow-
ing MI, resident macrophages [47], alongside fibroblasts
[27], release chemoattractant molecules that guide neu-
trophil recruitment to clear necrotic cardiomyocytes.
Given these key roles for resident macrophages it will
be interesting to know whether phenotypic changes in
response to age, obesity or systemic inflammation influ-
ence the likelihood of arrhythmia or the early inflamma-
tory response following MI. In the neonatal mouse heart,www.sciencedirect.com
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Roles of resident macrophages in physiology and in pathophysiology following MI. Yolk-sac and fetal liver (YS/FL) derived macrophages that
predominate in the neonatal mouse heart are gradually replaced over the lifetime by bone-marrow (BM) derived macrophages that may provoke a
greater inflammatory response to injury. Macrophages have a phagocytic role in the healthy mouse heart and in the atrio-ventricular conducting
system are required for electrical signaling. Following MI, macrophages are required for angiogenesis in neonatal and adult mice, and may have a
role in regulating cardiomyocyte proliferation under hypoxic conditions, at least in neonates. Macrophages are important for scar removal in
neonatal mice to ensure scar free regeneration, but influence fibroblast activation in the adult to ensure formation of a replacement scar in the
absence of efficient regeneration.macrophages are required for cardiac regeneration, where
their role is to support vascularization and scar resolution
[48], although it has been suggested that they also pro-
mote cardiomyocyte proliferation under conditions of
hypoxia [49]. Resident cardiac macrophages do not pro-
liferate in situ in response to a Th2 immune stimulus [45],
unlike resident populations in some other tissues, and are
rapidly outnumbered by macrophages derived from
recruited monocytes soon after MI [41]. An important
area for future investigation will be the status of the
resident macrophage population after inflammation reso-
lution and how this influences longer term cardiac remo-
deling and the response to subsequent cardiovascular
insult, be it ischemia or pressure overload.
Future directions
As our understanding of the molecular mechanisms
involved in myocardial injury, repair and regeneration
increases what emerges is a picture of integrated signaling
among the multiple resident cell types of the myocar-
dium, and between these cells and those recruited to the
heart. The extracellular matrix is coming to the fore [50]
with its ability to communicate changes in biomechanical
strain and to secrete molecules that influence the cells
that it surrounds. The microenvironment in the infarct,
peri-infarct and remote myocardium varies during injurywww.sciencedirect.com and repair and determines the phenotype and activation
status of cells including fibroblasts, endothelial cells and
macrophages, ensuring progression from removal of dead
cells to their replacement by scar in the adult, or by new
myocardial tissue in the neonate. Aging and co-morbid-
ities such as obesity and diabetes will undoubtedly influ-
ence these cellular interactions. As we move closer to
effective enhancement of cardiomyocyte proliferation in
the adult heart, the challenge will be to bring these
elements together so that we can better understand
how to promote myocardial regeneration and scar
removal, while maintaining the integrity and pump func-
tion of the heart. Advances in molecular imaging [51],
single cell sequencing and in silico modeling of biological
processes [52] may best provide the means to achieve this
end.
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